RCn
RC16 is a Novel Class of Amphiphilic Amines as Antitumor Agents and Nanocarriers for Bioactive Molecules.
Open Therapeutics™ facilitates and enables collaboration among life science researchers around the world!
Here are some of the technologies you will find within Therapoid:
RC16 is a Novel Class of Amphiphilic Amines as Antitumor Agents and Nanocarriers for Bioactive Molecules.
These viruses attack cancer cells. They also stimulate the immune system to act against cancer cells.
By characterizing essential proteins, the global community can collaboratively develop antibiotics to target bacterial pathogens.
These microscopic organisms can perform many functions to include releasing medically important chemicals and killing cancer cells.